Plasma exchange in elderly patients

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 2, 2010, Pages 161-165

  Basic Jukic, Nikolina ^a   Brunetta, Bruna ^a   Kes, Petar ^a  

^a KBC Zagreb   (Croatia)

Author keywords

Complications; Elderly; Indication; Outcome; Plasma exchange

Indexed keywords

ALBUMIN;

AGED; ALLERGIC REACTION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DRUG INTOXICATION; FEMALE; GERIATRIC PATIENT; GOODPASTURE SYNDROME; GUILLAIN BARRE SYNDROME; HEMATOMA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPOTENSION; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYASTHENIA GRAVIS; PERIPHERAL VEIN; PLASMAPHERESIS; PNEUMOTHORAX; PRECORDIAL OPPRESSION; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR ACCESS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALBUMINS; DATABASES, FACTUAL; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MYASTHENIA GRAVIS; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77950293794     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00793.x     Document Type: Article

References (32)

1. Kaplan AA. Therapeutic apheresis for renal disorders. Ther Apher 1999 3 : 25 30.
2. Basic-Jukic N, Kes P, Basic-Kes V, Brunetta B. Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration. Acta Med Croatica 2004 58 : 63 6.
3. Basic-Jukic N, Kes P, Brunetta B. Fatal relapse of thrombotic thrombocytopaenic purpura after cardiac surgery in patient with congenital absence of vWF-cleaving protease activity. Nephrol Dial Transplant 2006 21 : 1734 1735.
4. Basic-Jukic N, Kes P, Bubic-Filipi L, Brunetta B. Treatment of thrombotic microangiopathies with plasma exchange. Hematology 2007 12 : 63 7.
5. Kes P, Basic V. Plasmapheresis in neurologic disorders. Acta Clin Croat 2000 39 : 237 245.
6. Kes P, Pecanic Z, Getaldic B, Ratkovic-Gusic I. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias. Acta Med Croat 1996 50 : 173 177.
7. Kaplan AA. A Practical Guide to Therapeutic Plasma Exchange. Malden, MA : Blackwell Science, 1999.
8. Kes P. Therapeutic plasma exchange. Acta Med Croat 1999 53 : 129 139.
9. Weinstein R. Therapeutic apheresis in neurological disorders. J Clin Apher 2000 15 : 74 128.
10. American Association of Blood Banks Hemapheresis Committee. Guidelines for Therapeutic Hemapheresis. Bethesda, MD : American Association of Blood Banks, 1995.
11. The Clinical Applications Committee of the American Society for Apheresis. Clinical applications of therapeutic apheresis. J Clin Apher 1986 3 : 1 97.
12. Szczepiorkowski ZM, Bandarenko N, Kim HC et al. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2007 22 : 106 175.
13. Kaplan AA. A simple an accurate method for prescribing plasma exchange. ASAIO Trans 1990 36 : 597 599.
14. Clark WF, Rock GA, Buskard N et al. Therapeutic plasma exchange an update from the Canadian apheresis group. Ann Intern Med 1999 131 : 453 462.
15. Ilhan O, Uskent N, Arslan O et al. National survey of hemapheresis practice in Turkey (1998). Transfus Sci 2000 22 : 195 201.
16. Korach JM, Guillevin L, Petitpas D, Berger P, Chilet V. Apheresis registry in France: indications, techniques, and complications. French registry group. Ther Apher 2000 4 : 207 210.
17. Narciso CT. Therapeutic apheresis in the Philippines. Transfus Apher Sci 2005 33 : 3 9.
18. Norda R, Axelsson CG, Axdorph U et al. Recognition of intercenter differences may help develop best practice. Ther Apher Dial 2008 12 : 347 354.
19. Passalacqua S, Steffolani E, Busnach G et al. The Italian registry for Therapeutic Apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology. J Clin Apher 2005 20 : 101 106.
20. Petitpas D, Ould-Zein S, Korach JM. What are the indications for plasma exchange in autoimmune diseases? The registry of the Société Française d'Hémaphérèse. Transfus Apher Sci 2007 36 : 173 177.
21. Rock G, Clark B, Sutton D. The Canadian apheresis registry. Transfus Apher Sci 2003 29 : 167 177.
22. Rock G, Herbert C. The Canadian apheresis group and therapeutic plasma exchange. Transfus Sci 1999 20 : 145 150.
23. Song EY, Kwon SW, Kim DS et al. Current status of therapeutic plasma exchange in Korea. Ther Apher Dial 2004 8 : 97 101.
24. Stegmayr B, Ptak J, Wikstrom B. World apheresis registry report. Transfus Apher Sci 2007 36 : 13 16.
25. Yeh JH, Chiu HC. Therapeutic apheresis in Taiwan. Ther Apher 2001 5 : 513 516.
26. Belak M, Jako J. National survey of hemapheresis in Hungary 2001-2004. Ther Apher Dial 2007 11 : 22 9.
27. Hughes R. The role of IVIg in autoimmune neuropathies: the latest evidence. J Neurol 2008 255 : 7 11.
28. Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 2005 9 : 391 395.
29. McLeod BC, Sniecinski I, Ciavarella D et al. Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion 1999 39 : 282 288.
30. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: Complications and management. Am J Kidney Dis 1994 23 : 817 827.
31. Schinzel H, Berghoff K, Beuermann I, Sauer O, von Mach MA, Weilmann LS. Anticoagulation with low-molecular weight heparin (dalteparin) in plasmapheresis therapy: initial experience. Transfusion 2006 46 : 624 629.
32. Sabloff M, Wells PS. The effect of plasmapheresis on the serum activity level of dalteparin: a case report. Blood Coagul Fibrinolysis 2000 11 : 395 400.